FDA Clearance Tracker · P800022
ZYDERM COLLAGEN IMPLANT (ZYDERM CI)
Last checked: Nov 19, 2026Latest source record: Jul 22, 1981 (this decision)Source: openFDAMethods & limitations
Decided
Jul 22, 1981
Approval withdrawn
Time to decision
446 days
Received May 2, 1980. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P800022
- Device name
- ZYDERM COLLAGEN IMPLANT (ZYDERM CI)
- Applicant
- Allergan
- Applicant location
- Goleta, CA
- Received
- May 2, 1980
- Decided
- Jul 22, 1981
- Decision
- Approval withdrawn
- Supplements
- 45 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code LMH (Implant, dermal, for aesthetic use).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Allergan
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SKINVIVE by JUVEDERM®PMA supplement
P110033-S099 · Decided Jun 11, 2026 · 394 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
K233732 · Decided Sep 12, 2024 · 296 days after receipt
Device type: Dermal Cooling Pack/Vacuum/Massager (OOK) · General & Plastic Surgery
- Juvéderm® Voluma® XCPMA supplement
P110033-S070 · Decided Oct 6, 2023 · 177 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.